
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Analysis of [VRTX] Vertex Pharmaceuticals Inc.
Data updated 2025-Apr-30 (Wednesday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab
Share
2025-Apr-30 Wednesday
Open | $500.79 | High | $510.77 +1.99% |
---|---|---|---|
Close | $509.50 | Low | $497.34 -0.69% |
Volume | 1.42 Million 1.07x | Volatility | 2.70% |
Change |
+$6.00
+1.19%
|
Streak | ↑ 7 days +6.70% |
20d SMA | $487.93 +4.4% | 50d SMA | $491.09 +3.7% | 100d SMA | $465.42 +9.5% | 200d SMA | $471.41 +8.1% |
RSI | 62 | MACD | 2.22 | ADX | 22.1 | Stochastic Oscillator | 93.3 89.1 |
CCI | 159.0 | ATR | 14.43 | OBV | 219 Million | Chaikin A/D | 475 Million |
Market Cap | 106 B | PEG Ratio | 0.55 | Trailing P/E | 29.5 | Forward P/E | 25.1 |
Price/Sales (ttm) | 10.8 | Price/Book (mrq) | 6.02 | EV/Revenue (ttm) | 9.65 | EV/EBITDA (ttm) | 20.7 |
% Held by Insiders | 0.11% | % Held by Institutions | 95.84% | Shares Short | 4.13 M | Shares Short (prior month) | 4.13 M |
Short Ratio | 3.77 | Short % of Outstanding | 1.60% | Short % of Float | 1.60% | Shares Short Change (mom) | 0.0% |
Revenue/Share (ttm) | $38.30 | Profit Margin (ttm) | 36.68% | Operating Margin (ttm) | 37.97% | EBITDA (ttm) | 4.48 B |
Diluted EPS (ttm) | $13.86 | Current Ratio (mrq) | 3.99 | Return on Assets (ttm) | 13.17% | Return on Equity (ttm) | 22.99% |
Qtr Earnings Growth (yoy) | 18.30% | Qtr Revenue Growth (yoy) | 9.30% | Operating Cash Flow (ttm) | 3.54 B | Free Cash Flow (ttm) | 3.51 B |
Choose view type
Daily Performance for Vertex Pharmaceuticals Inc.. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Note: Performance over Key Timeperiods for Vertex Pharmaceuticals Inc. up to close of 2025-Apr-30 at $509.50
Period | Frequency | Performance | % off High | % off Low | Volatility | % off SMA | % off EMA | Relative Volume |
---|---|---|---|---|---|---|---|---|
01 Trailing 5-days
|
|
+3.47%
|
-0.2%
|
+5.2%
|
5.4%
|
+2.1%
|
+1.7%
|
1.07x
|
02 Trailing 10-days
|
|
+1.80%
|
-0.2%
|
+7.7%
|
8.0%
|
+3.3%
|
+2.7%
|
0.79x
|
03 Trailing 20-days
|
|
+5.11%
|
-0.2%
|
+13.7%
|
14.0%
|
+4.4%
|
+3.4%
|
1.12x
|
04 Trailing 30-days
|
|
-0.53%
|
-1.2%
|
+13.7%
|
15.1%
|
+3.5%
|
+3.8%
|
1.06x
|
05 Trailing 50-days
|
|
+10.26%
|
-2.0%
|
+13.7%
|
16.0%
|
+3.7%
|
+4.8%
|
0.94x
|
06 Trailing 100-days
|
|
+11.50%
|
-2.0%
|
+34.8%
|
37.5%
|
+9.5%
|
+6.8%
|
1.16x
|
07 Trailing 200-days
|
|
+4.25%
|
-2.0%
|
+34.8%
|
37.6%
|
+8.1%
|
+9.5%
|
1.03x
|
08 Month-to-date
|
|
+5.09%
|
-0.2%
|
+13.7%
|
14.0%
|
|
|
|
09 Quarter-to-date
|
|
+5.09%
|
-0.2%
|
+13.7%
|
14.0%
|
|
|
|
10 Year-to-date
|
|
+26.52%
|
-2.0%
|
+28.3%
|
30.8%
|
|
|
|
11 Trailing 52-weeks
|
|
+29.71%
|
-2.0%
|
+34.8%
|
37.6%
|
|
|
|
6-month Performance Benchmarks for Vertex Pharmaceuticals Inc.:
Related to Vertex Pharmaceuticals Inc.
Information for Vertex Pharmaceuticals Inc.
Current Detail : Recent daily/monthly performance & benchmark comparison Currently Viewing
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Apr-30 on Google
SEC Reports : Quarterly reports around 2025-Apr-30 on SEC Edgar
Compare Vertex Pharmaceuticals Inc. with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Vertex Pharmaceuticals Inc.
Industry : Biotechnology industry performance which includes Vertex Pharmaceuticals Inc.